ArticleJournal of oncology2022

Clinical Efficacy and Safety of Bevacizumab, Apatinib, and Recombinant Human Endothelial Inhibitor in the Treatment of Advanced Gastric Cancer.

Liang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.